{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:13:30Z","timestamp":1789582410342,"version":"build-2803163510"},"reference-count":38,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"BIAL\u2013Portela & C\u00aa, S.A"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>While sleep disturbances are among the most frequent non-motor symptoms of Parkinson's disease (PD), there is a lack of evidence to support its treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the efficacy of opicapone 50\u2005mg in treating sleep disturbances in patients with PD and end-of-dose motor fluctuations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>OASIS was an exploratory, open-label, single-arm clinical trial in PD patients with end-of-dose motor fluctuations and associated sleep disturbances. The primary endpoint was change from baseline to week 6 in Parkinson's Disease Sleep Scale 2 (PDSS-2). Secondary endpoints included functional motor and non-motor assessments (Movement Disorder Society [MDS]-Unified Parkinson's Disease Rating Scale [UPDRS], MDS-Non-motor Scale [NMS], 8-item PD Questionnaire [PDQ-8], 16-item PD Fatigue Scale [PFS-16], ON\/OFF home diary), Clinical and Patient Global Impression of Change (CGI-C; PGI-C) and adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At week 6, there was a significant reduction of \u22127.9 points (95%CI \u221213.6, \u22122.2;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.0099) in PDSS-2 total score, with a significant mean change of \u22124.7 in the PDSS-2 domain of disturbed sleep (95%CI: \u22127.2, \u22122.3;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.0009). Significant reductions were also observed in PFS-16 (\u22129.6;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.0211), MDS-NMS total score (\u221228.9;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.0015), MDS-UPDRS-III (\u22126.3;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.0253), MDS-UPDRS-IV (\u22121.2;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.0044) and PDQ-8 (\u221214.2;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.0051). Absolute OFF-time was reduced (\u2212142.1\u2005min). Most patients (93.3%) and most clinicians (80.0%) reported improvements on PGI-C and CGI-C, respectively. Opicapone was well tolerated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adding opicapone 50\u2005mg to levodopa\/DDCI therapy in patients with PD and motor fluctuations and sleep disturbances improved both sleep disturbances and OFF time in these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1877718x241306711","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T03:32:38Z","timestamp":1737084758000},"page":"87-96","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Opicapone for Parkinson's disease-related sleep disturbances: The OASIS clinical trial"],"prefix":"10.1177","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3950-5113","authenticated-orcid":false,"given":"Joaquim J","family":"Ferreira","sequence":"first","affiliation":[{"name":"IMM Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal"},{"name":"CNS-Campus Neurol\u00f3gico, Torres Vedras, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel F","family":"Gago","sequence":"additional","affiliation":[{"name":"Department of Neurology, ULS Alto Ave, Hospital da Senhora da Oliveira, Guimar\u00e3es, Portugal"},{"name":"Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal"},{"name":"CNS \u2013 Campus Neurol\u00f3gico, Braga, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Costa","sequence":"additional","affiliation":[{"name":"BIAL \u2013 Portela &amp; Ca S.A., Coronado, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel M","family":"Fonseca","sequence":"additional","affiliation":[{"name":"BIAL \u2013 R&amp;D Investments, S.A., Coronado, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Almeida","sequence":"additional","affiliation":[{"name":"BIAL \u2013 Portela &amp; Ca S.A., Coronado, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2611-4850","authenticated-orcid":false,"given":"Jos\u00e9 Francisco","family":"Rocha","sequence":"additional","affiliation":[{"name":"BIAL \u2013 Portela &amp; Ca S.A., Coronado, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7967-8732","authenticated-orcid":false,"given":"Joerg","family":"Holenz","sequence":"additional","affiliation":[{"name":"BIAL \u2013 Portela &amp; Ca S.A., Coronado, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Trenkwalder","sequence":"additional","affiliation":[{"name":"Paracelsus-Elena Klinik, Kassel, Germany"},{"name":"Department of Neurosurgery, University Medical Center, Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"e_1_3_5_2_2","first-page":"381","article-title":"Sleep and Parkinson disease","volume":"114","author":"Bollu PC","year":"2017","unstructured":"Bollu PC, Sahota P. Sleep and Parkinson disease. Mo Med 2017; 114: 381\u2013386.","journal-title":"Mo Med"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2018.11.021"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.5152\/npa.2016.12758"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.3148"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00042"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22643"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2008.02056.x"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002509"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2008.06296.x"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23875"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70521-X"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28215"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26125"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2016.08.001"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1017\/S031716710000007X"},{"key":"e_1_3_5_17_2","unstructured":"BIAL \u2013 Portela & Ca SA. Ongentys\u00ae Summary of Product Characteristics https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/ongentys-epar-product-information_en.pdf (2021 accessed 21 February 2024)."},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.994114"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00336-1"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2017.1336086"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-020-00187-1"},{"key":"e_1_3_5_22_2","unstructured":"UK Parkinson's Disease Society. UK Parkinson\u2019s Disease Society Brain Bank Clinical Diagnostic Criteria https:\/\/www.ncbi.nlm.nih.gov\/projects\/gap\/cgi-bin\/GetPdf.cgi?id=phd000042 (2006 accessed 21 February 2024)."},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26424"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23476"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2004.07.007"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12728"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27862"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22340"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/08870449708406741"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20248"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.4103\/2229-3485.159943"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12749"},{"key":"e_1_3_5_33_2","first-page":"970534","article-title":"Minimal clinically important difference on Parkinson's disease sleep scale 2nd version","volume":"2015","author":"Horv\u00e1th K","year":"2015","unstructured":"Horv\u00e1th K, Aschermann Z, \u00c1cs P, et al. Minimal clinically important difference on Parkinson's disease sleep scale 2nd version. Parkinsons Dis 2015; 2015: 970534.","journal-title":"Parkinsons Dis"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2021.02.036"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106971"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-023-02654-1"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306104"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27602"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2010.03.008"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X241306711","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X241306711","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X241306711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:51:01Z","timestamp":1777589461000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X241306711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1177\/1877718X241306711"],"URL":"https:\/\/doi.org\/10.1177\/1877718x241306711","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}